T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.
Middelburg J, Sluijter M, Schaap G, Göynük B, Lloyd K, Ovcinnikovs V, Zom GG, Marijnissen RJ, Groeneveldt C, Griffioen L, Sandker GGW, Heskamp S, van der Burg SH, Arakelian T, Ossendorp F, Arens R, Schuurman J, Kemper K, van Hall T.
Middelburg J, et al.
Nat Commun. 2024 Jan 2;15(1):48. doi: 10.1038/s41467-023-44308-6.
Nat Commun. 2024.
PMID: 38167722
Free PMC article.